2022 annual financial data
BriaCell Therapeutics Corp. - Common Shares 2022 Operating margin
BriaCell Therapeutics Corp. - Common Shares 2022 operating margin with verified…
Direct answer
Operating margin was Not calculable.
Operating income was -19,607,684 USD and net income was -34,420,222 USD.
Operating cash flow was -15,874,365 USD.
Get free BriaCell Therapeutics Corp. - Common Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -19,607,684 USD
- Net income
- -34,420,222 USD
- Operating cash flow
- -15,874,365 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all BriaCell Therapeutics Corp. - Common Shares financial years